A new mRNA vaccine could prevent melanoma from returning
A new mRNA vaccine has shown promise in preventing the return of melanoma in high-risk patients, according to Moderna and Merck. The vaccine was tested in patients with high-risk melanoma and demonstrated its ability to prevent the cancer's return and spread.
AI-generated summary
Read this story on The Seattle Times